Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer

摘要

The present invention relates to methods and compositions for treating and preventing cancer by administering a therapeutically effective dose of fusion cells formed by fusion of autologous dendritic cells and autologous non-dendritic cells, in combination with a cytokine or other molecule which stimulates or induces a cytotoxic T cell response and/or a humoral immune response.